The shares of Fastenal Company (NASDAQ:FAST) has been pegged with a rating of Neutral by Buckingham Research in its latest research note that was published on June 14th, 2019. The research company has also assigned a $31 price target. Buckingham Research wasn’t the only research firm that published a report of Fastenal Company, with other equities research analysts also giving their opinion on the stock. William Blair advised investors in its research note published on May 7th, 2019, to Mkt Perform the FAST stock. The stock had earned Neutral rating from Northcoast when it published its report on April 15th, 2019. The stock was given Sector Weight rating by KeyBanc Capital Markets in its report released on February 12th, 2019. Jefferies was of a view that FAST is Hold in its latest report on January 7th, 2019 while giving it a price target of $60. Morgan Stanley thinks that FAST is worth Equal-Weight rating. This was contained in the firm’s report on December 18th, 2018 in which the stock’s price target was also moved to $55.
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 13 believe it has the potential for further growth, thus rating it as Hold while 3 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $32.38. The price of the stock the last time has raised by 24.81% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 45.98.
The shares of the company added by 1.94% during the trading session on Tuesday, reaching a low of $29.21 while ending the day at $29.96. During the trading session, a total of 6.54 million shares were traded which represents a -41.24% decline from the average session volume which is 4.63M shares. FAST had ended its last session trading at 29.39. Fastenal Company currently has a market cap of $17.18B, while its P/E ratio stands at 22.75, while its P/E earnings growth sits at 3.31, with a beta of 1.21. Fastenal Company debt-to-equity ratio currently stands at 0.20, while its quick ratio hovers at 2.10. FAST 52-week low price stands at $24.00 while its 52-week high price is $35.94.
The company in its last quarterly report recorded $0.36 earnings per share which is below the $0.37 predicted by most analysts. The Fastenal Company generated $1,368.40 million in revenue during the last quarter, which is slightly lower than the $1,378.16 million predicted by analysts. In the second quarter last year, the firm recorded $0.34 earnings per share. Compared to the same quarter last year, the firm’s revenue was up by 5.56%. Fastenal Company has the potential to record 1.32 EPS for the current fiscal year, according to equities analysts.
Investment analysts at KeyBanc Capital Markets published a research note on August 7th, 2019 where it informed investors and clients that Medical Properties Trust, Inc. (NYSE:MPW) is now rated as Overweight. Their price target on the stock stands at $20. William Blair also rated MPW as Downgrade on May 7th, 2019, with its price target of $200 suggesting that MPW could surge by 12.29% from its current share price. Even though the stock has been trading at $17.84/share, analysts expect it to surge higher by 0.06% to reach $20.35/share. It started the day trading at $17.91 and traded between $17.65 and $17.85 throughout the trading session.
A look at its technical shows that MPW’s 50-day SMA is 17.95 while its 200-day SMA stands at 17.57. The stock has a high of $18.92 for the year while the low is $13.98. The company’s P/E ratio currently sits at 6.46, while the P/B ratio is 1.39. At the moment, only of Medical Properties Trust, Inc. shares were sold short. The company’s average trading volume currently stands at 4.37M shares, which means that the short-interest ratio is just 3.95 days. Over the past seven days, the company moved, with its shift of 2.12%. Looking further, the stock has dropped -0.72% over the past 90 days while it lost -1.65% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc bought more MPW shares, increasing its portfolio by +5.25% during the last quarter. This move now sees The Vanguard Group Inc purchasing 2,812,739 shares in the last quarter, thus it now holds 56,415,474 shares of MPW, with a total valuation of $987,270,795. BlackRock Fund Advisors meanwhile bought more MPW shares in the recently filed quarter, changing its stake to $662,766,353 worth of shares. Massachusetts Financial Services followed the path by increasing its MPW portfolio by +13.10% in the quarter. This means that Massachusetts Financial Services bought 2,557,332 shares in the last quarter and now controls 22,082,946 shares of the MPW stock, with the valuation hitting $386,451,555.
Similarly, LSV Asset Management decreased its Medical Properties Trust, Inc. shares by -10.03% during the recently filed quarter. After selling -1,047,102 shares in the last quarter, the firm now controls 9,397,605 shares of Medical Properties Trust, Inc. which are valued at $164,458,088. In the same vein, Mellon Investments Corp increased its Medical Properties Trust, Inc. shares by during the most recent reported quarter. The firm bought 609,970 shares during the quarter which increased its stakes to 8,189,714 shares and is now valued at $143,319,995. Following these latest developments, around 1.20% of Medical Properties Trust, Inc. stocks are owned by institutional investors and hedge funds.